Fig. 2

The constructed nomogram for predicting in-hospital death risk of nosocomial infections in cancer patients. This patient is a 65 years old female diagnosed with stage IV colorectal cancer (T4aN2bM1) and received bevacizumab plus irinotecan and S-1 for anti-tumor therapy. This patient was admitted to our hospital due to urgently occurred fever and chill and was diagnosed with BSI caused by ESBL-producing E. coli through a blood culture. Unfortunately, the patient eventually died of septic shock even an intense antimicrobial regimen was initiated. According to the nomogram, we can calculate that the total point for this patient is 438 and its corresponding in-hospital death risk is 87.6%